Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 996 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits
Questions to guide the decision: Do you have any chronic health conditions like diabetes, kidney disease, liver disease, or thyroid disorders
B.MelnykO.EdwardsR
No clinical trial has fixed meal timing around retatrutide injections
Ozempic intentionally slows gastric emptying as part of its therapeutic mechanism to control blood glucose and promote satiety
doi:10.1002/mabi.202200019 Canapp SO, Farese JP, Schultz GS, et al